Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma

G. Schwefel (Rostock, Germany), K. Bratke (Rostock, Germany), H. Marchewski (Rostock, Germany), J. Virchow (Rostock, Germany), M. Lommatzsch (Rostock, Germany)

Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Session: Precision meets immunology in treatment of airway diseases
Session type: Oral Presentation
Number: 3801
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Schwefel (Rostock, Germany), K. Bratke (Rostock, Germany), H. Marchewski (Rostock, Germany), J. Virchow (Rostock, Germany), M. Lommatzsch (Rostock, Germany). Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma. 3801

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Upregulation of the high-affinity IgE receptor on plasmacytoid dendritic cells in severe COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015


Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Late Breaking Abstract - IgE-FceR1 cross-linking impairs the capacity of plasmacytoid dendritic cells to induce in vitro functional regulatory T cells which can be restored by Omalizumab
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019



Late Breaking Abstract - Enhanced IL-33 response in differentiated human TH2 cells carrying the IL-1RL1 asthma risk genotype
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021


Phenotype of dendritic cells (DCs) stimulated by microbial antigens in COPD patients with frequent and infrequent exacerbations.
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017

Treatment with Omalizumab in adults with severe allergic reduces Fc?I expression on dendritic cells and improves antiviral responses.
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019

Decreased regulation of lung CD8+ T cells by virally-infected macrophages in COPD: Role of PD1/PDL1 axis
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015

LSC - 2019 - Anti-IL5 in mild asthma alters rhinovirus-induced macrophage, B cell and neutrophil responses
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019

Circulating mature and progenitor eosinophils in patients with stable asthma express all major traffic related receptors
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012

Generation from peripheral blood CD34+ progenitors of a novel NK-2 subset that produces IL-21 and renders tolerogenic myeloid dendritic cells. A paradox for allergy treatment?
Source: Eur Respir J 2007; 30: Suppl. 51, 135s
Year: 2007

Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011


Regulatory T cells and L-selectin in severe asthmatic patients treated with mepolizumab.
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020


Increase of both blood CXCR3+ and CCR4+ helper T cells associated with severity of asthma
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005


Reduced numbers of circulating CD4+CD25highFOXP3+ regulatory T cells in patients with allergic asthma
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008


Infiltration of mast cells with increased IgE-receptor expression in peripheral lung of patients with uncontrolled asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010

Heterogeneous levels of CD86+CD209+ and CD83+CD209+ dendritic cells in patients with different severity of bronchial asthma
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013


Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


Altered phenotype of blood dendritic cells in patients with acute pneumonia
Source: Annual Congress 2011 - Phagocytes and dendritic cells
Year: 2011

Late Breaking Abstract - Characterization of the immunological profile of COVID-19 patients and correlation of CD4+ and CD8+ T lymphocytes with disease severity during hospitalization.
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021



TLR 7/8 agonist resiquimod alleviates murine allergic asthma through IL-27 production and up regulation of B7-H1 on antigen presenting cells
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015